Novel MFSD7‐ATP5I fusion promotes migration and invasion of human sarcoma
- 2 October 2023
- journal article
- research article
- Published by Wiley in Journal of Orthopaedic Research
- Vol. 42 (2) , 443-452
Abstract
Fusion genes have been implicated in the development and progression of several types of sarcomas, serving as valuable diagnostic and prognostic markers, as well as potential therapeutic targets. We discovered a novel major facilitator superfamily domain‐containing 7 (MFSD7) and adenosine triphosphate 5I (ATP5I) gene fusion from sarcomas. In this study, the MFSD7‐ATP5I fusion transcript was screened using RNA sequencing in 55 sarcoma samples and sixteen normal samples. The MFSD7‐ATP5I fusion transcript was detected in 58% of sarcoma samples. The correlation between the expression of MFSD7‐ATP5I fusion transcript and clinicopathological information was analyzed, and MFSD7‐ATP5I expression is associated with marked pleomorphism and lower tumor necrosis. Cell migration and invasion was significantly reduced by knock‐down of MFSD7‐ATP5I. Cell migration and invasion was increased by overexpression of MFSD7‐ATP5I. A phosphokinase assay demonstrated that MFSD7‐ATP5I is involved in the GSK‐3 pathway. The current study found that MFSD7‐ATP5I is associated with increasing pleomorphism and decreasing necrosis of tumors. And our gain and loss of function experiments prove that MFSD7‐ATP5I promotes the invasiveness of tumor cells.Keywords
Funding Information
- National Research Foundation of Korea (2021R1A2B5B02086271)
This publication has 35 references indexed in Scilit:
- Intra-tumor Genetic Heterogeneity and Mortality in Head and Neck Cancer: Analysis of Data from The Cancer Genome AtlasPLOS Medicine, 2015
- Evolving techniques for gene fusion detection in soft tissue tumoursHistopathology, 2013
- Heme and FLVCR-related transporter families SLC48 and SLC49Molecular Aspects of Medicine, 2013
- Advances in sarcoma genomics and new therapeutic targetsNature Reviews Cancer, 2011
- Recurrent chimeric RNAs enriched in human prostate cancer identified by deep sequencingProceedings of the National Academy of Sciences, 2011
- Intra-tumour genetic heterogeneity and poor chemoradiotherapy response in cervical cancerBritish Journal of Cancer, 2010
- Risk of Ovarian Cancer and Inherited Variants in Relapse-Associated GenesPLOS ONE, 2010
- The impact of translocations and gene fusions on cancer causationNature Reviews Cancer, 2007
- The paradoxical pro- and anti-apoptotic actions of GSK3 in the intrinsic and extrinsic apoptosis signaling pathwaysProgress in Neurobiology, 2006
- Identification of novel genes, SYT and SSX, involved in the t(X;18)(p11.2;q11.2) translocation found in human synovial sarcomaNature Genetics, 1994